z-logo
open-access-imgOpen Access
SUMO1 promotes the proliferation and invasion of non‐small cell lung cancer cells by regulating NF‐κB
Author(s) -
Ke Changkang,
Zhu Kai,
Sun Ying,
Ni Yunfeng,
Zhang Zhipei,
Li Xiaofei
Publication year - 2019
Publication title -
thoracic cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 28
eISSN - 1759-7714
pISSN - 1759-7706
DOI - 10.1111/1759-7714.12895
Subject(s) - cell growth , cancer research , lung cancer , cell culture , adenocarcinoma , a549 cell , small hairpin rna , medicine , cell cycle , cell , nf κb , cancer , biology , pathology , gene knockdown , inflammation , genetics
Background Our previous study showed that SUMO1 expression is closely related to progression in non‐small cell lung cancer (NSCLC); however, the function of SUMO1 in NSCLC has not yet been well elucidated. Methods SUMO1 was enhanced or silenced in two NSCLC cell lines by using either forced SUMO1 expression or short hairpin RNA against SUMO1 lentiviral vectors, respectively. The biological functions of SUMO1 in NSCLC were investigated through colony‐formation, cell proliferation, and invasion assays, and cell cycle analysis. NF‐κB expression was detected in the overexpressed and silenced SUMO1 cell lines. Immunohistochemistry was used to detect an association between SUMO1 and NF‐κB in the cancer and adjacent tissues of 168 patients with lung cancer. Results Overexpressed SUMO1 promoted the proliferation rate, colony formation ability, invasion, and NF‐κB expression in an A549 cell line. Conversely, SUMO1 depletion inhibited the cell growth rate, colony formation ability, invasion, and NF‐κB expression in a Calu‐1 cell line. SUMO1 expression was significantly correlated with NF‐κB expression in lung adenocarcinoma and squamous carcinoma patients ( r  > 0.5, P  < 0.001). Conclusion Our results provide evidence that SUMO1 promotes the proliferation and invasion of NSCLC cells by regulating NF‐κB.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here